Literature DB >> 12829852

Biphasic DNA synthesis in spumaviruses.

Olivier Delelis1, Ali Saïb, Pierre Sonigo.   

Abstract

Spumaviruses are complex retroviruses whose replication cycle resembles that of hepadnaviruses, especially by a late-occurring reverse transcription step. The possible existence of an early reverse transcription as observed in other retroviruses was not documented. Using real-time quantitative PCR, we addressed directly the kinetics of DNA synthesis during spumavirus infection. An early phase of viral DNA synthesis developed until 3 h postinfection, followed by a second phase, culminating 10 h postinfection. Both phases were abolished by the reverse transcriptase inhibitor 3'-azido-3'-deoxythymidine. Similar to other retroviruses, circular forms of viral DNA harboring two long terminal repeats were mainly found in the nucleus of infected cells. Interestingly, a fraction of these circular forms were detected in the cytoplasm and in extracellular virions, a feature shared with hepadnaviruses. Combined with packaging of both viral DNA and RNA genomes in virions, early and late reverse transcription might allow spumavirus to maximize its genome replication.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829852      PMCID: PMC161954          DOI: 10.1128/jvi.77.14.8141-8146.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Human foamy virus reverse transcription that occurs late in the viral replication cycle.

Authors:  A Moebes; J Enssle; P D Bieniasz; M Heinkelein; D Lindemann; M Bock; M O McClure; A Rethwilm
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Characterization of HIV replication complexes early after cell-to-cell infection.

Authors:  L Karageorgos; P Li; C Burrell
Journal:  AIDS Res Hum Retroviruses       Date:  1993-09       Impact factor: 2.205

Review 3.  Reverse transcriptase jumps and gaps.

Authors:  J J Kupiec; P Sonigo
Journal:  J Gen Virol       Date:  1996-09       Impact factor: 3.891

4.  Identification of a human population infected with simian foamy viruses.

Authors:  W Heneine; W M Switzer; P Sandstrom; J Brown; S Vedapuri; C A Schable; A S Khan; N W Lerche; M Schweizer; D Neumann-Haefelin; L E Chapman; T M Folks
Journal:  Nat Med       Date:  1998-04       Impact factor: 53.440

5.  Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step.

Authors:  A Saïb; F Puvion-Dutilleul; M Schmid; J Périès; H de Thé
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Kinetic analysis of HIV-1 early replicative steps in a coculture system.

Authors:  P Barbosa; P Charneau; N Dumey; F Clavel
Journal:  AIDS Res Hum Retroviruses       Date:  1994-01       Impact factor: 2.205

7.  Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses.

Authors:  D Trono
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

8.  Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay.

Authors:  S F Yu; M L Linial
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses.

Authors:  S F Yu; D N Baldwin; S R Gwynn; S Yendapalli; M L Linial
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

10.  Integration of murine leukemia virus DNA depends on mitosis.

Authors:  T Roe; T C Reynolds; G Yu; P O Brown
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  30 in total

1.  Structural studies of the catalytic core of the primate foamy virus (PFV-1) integrase.

Authors:  Stéphane Réty; Lenka Reaeábková; Barbara Dubanchet; Jan Silhán; Pierre Legrand; Anita Lewit-Bentley
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-07-27

2.  Nonintegrating foamy virus vectors.

Authors:  David R Deyle; Yi Li; Erik M Olson; David W Russell
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis.

Authors:  Erik Müllers; Tobias Uhlig; Kristin Stirnnagel; Uwe Fiebig; Hanswalter Zentgraf; Dirk Lindemann
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

4.  Protease-dependent uncoating of a complex retrovirus.

Authors:  Jacqueline Lehmann-Che; Marie-Lou Giron; Olivier Delelis; Martin Löchelt; Patricia Bittoun; Joelle Tobaly-Tapiero; Hugues de Thé; Ali Saïb
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Restriction of foamy viruses by APOBEC cytidine deaminases.

Authors:  Frédéric Delebecque; Rodolphe Suspène; Sara Calattini; Nicoletta Casartelli; Ali Saïb; Alain Froment; Simon Wain-Hobson; Antoine Gessain; Jean-Pierre Vartanian; Olivier Schwartz
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Expression of prototype foamy virus pol as a Gag-Pol fusion protein does not change the timing of reverse transcription.

Authors:  Dana L Jackson; Eun-Gyung Lee; Maxine L Linial
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

Review 7.  Human endogenous retrovirus-K (HML-2): a comprehensive review.

Authors:  Marta Garcia-Montojo; Tara Doucet-O'Hare; Lisa Henderson; Avindra Nath
Journal:  Crit Rev Microbiol       Date:  2018-10-14       Impact factor: 7.624

8.  Genomic flexibility of human endogenous retrovirus type K.

Authors:  Derek Dube; Rafael Contreras-Galindo; Shirley He; Steven R King; Marta J Gonzalez-Hernandez; Scott D Gitlin; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

9.  Early reverse transcription is essential for productive foamy virus infection.

Authors:  Alessia Zamborlini; Noémie Renault; Ali Saïb; Olivier Delelis
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

10.  Restriction of foamy viruses by primate Trim5alpha.

Authors:  Melvyn W Yap; Dirk Lindemann; Nicole Stanke; Juliane Reh; Dana Westphal; Helmut Hanenberg; Sadayuki Ohkura; Jonathan P Stoye
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.